These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 4141667)

  • 1. [Proceedings: T3 suppression test and TSH and prolactin reactions to TRH in patient with Basedow's disease under treatment with thyroid antagonists].
    Ikeda H; Imai Y; Uchimura H; Yamaji T; Matsuzaki S
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):108. PubMed ID: 4141667
    [No Abstract]   [Full Text] [Related]  

  • 2. [TSH and prolactin response to TRH in Basedow's disease].
    Gallamini A; Queirolo A; Peirano L; Barreca T
    Boll Soc Ital Biol Sper; 1976 Dec; 52(24):2077-81. PubMed ID: 829560
    [No Abstract]   [Full Text] [Related]  

  • 3. [Proceedings: T3 suppression test and TRH test for patients under treatment with anti-thyroid drugs for hyperthyroidism].
    Fujino R; Tamai H; Toshimi T; Sakuma M; Komiyama M
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):99. PubMed ID: 4141678
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of antithyroid treatment on the pituitary thyrotropin reserve in patients with Basedow's disease].
    Gianrossi R; Murialdo G; Gallamini A; Rolandi E
    Boll Soc Ital Biol Sper; 1976 Dec; 52(24):2082-7. PubMed ID: 71904
    [No Abstract]   [Full Text] [Related]  

  • 5. Responsiveness to thyrotropin releasing hormone and thyroid suppressibility in Graves' disease patients remaining in remission after antithyroid drug therapy.
    Rajatanavin R; Mahatumarat P; Poochanugool L; Kumpolpunth S; Himathongkam T
    J Med Assoc Thai; 1981 Jan; 64(1):11-8. PubMed ID: 6163837
    [No Abstract]   [Full Text] [Related]  

  • 6. [Proceedings: Relationship between thyroid functions and TRH test in Basedow's disease].
    Azukizawa M; Miyai K; Ishibashi K; Hosokawa M; Kumabara Y
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):107. PubMed ID: 4217703
    [No Abstract]   [Full Text] [Related]  

  • 7. [Proceedings: Recovery rate in Basedow's disease treated with thyroid antagonists: frequency of development of suppression 1 year after the initiation of the treatment].
    Nagataki S; Uchimura H; Ikeda H; Matsuzaki F; Imai Y
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):424. PubMed ID: 4141673
    [No Abstract]   [Full Text] [Related]  

  • 8. [TSH and prolactin studies with TRH-loading in juvenile Basedow's disease].
    Péter F; Breyer H; Kovács L
    Orv Hetil; 1986 May; 127(21):1243-6. PubMed ID: 3088510
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypothyroidism as a late sequela in patient with Graves' disease treated with antithyroid agents.
    Wood LC; Ingbar SH
    J Clin Invest; 1979 Nov; 64(5):1429-36. PubMed ID: 91625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of effects of antithyroid drug treatment based mainly on the TRH test].
    Irie M; Enomoto K; Inoue K; Enomoto H; Nukii T
    Horumon To Rinsho; 1974 Feb; 22(2):249-50. PubMed ID: 4136015
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chronologic study of free T3 and T4, of responses to TRH and of the suppression test during treatment of Basedow's disease].
    Jaffiol C; Baldet L; Castelnau P; Aberlenc M; Mirouze J
    Ann Endocrinol (Paris); 1978; 39(1):61-2. PubMed ID: 418732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity of thyroids to endogenous thyrotrophin in patients with Graves' disease.
    Tamai H; Nagai K; Uehata S; Komaki G; Kiyohara K; Miyauchi A; Kuma K; Kumagai LF; Nagataki S
    Exp Clin Endocrinol; 1990 Dec; 96(3):279-87. PubMed ID: 2128053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyrotropin-releasing hormone testing during antithyroid drug treatment of Graves' disease as an indicator of remission.
    Dahlberg PA; Karlsson FA; Jansson R; Wide L
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1100-4. PubMed ID: 2414311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of hyperthyroidism in children with antithyroid drugs and the results of T3 inhibition and TRH tests].
    Niimi H; Matsumoto S; Kubimura N; Sasaki N; Hoshina K
    Horumon To Rinsho; 1974 Oct; 22(10):1153-5. PubMed ID: 4141286
    [No Abstract]   [Full Text] [Related]  

  • 15. [Results of thyrostatic therapy of hyperthyroidism in patients with Basedow's disease and disseminated autonomy].
    Meng W; Meng S; Hampel R; Ventz M; Männchen E; Weber W; Streckenbach B
    Dtsch Z Verdau Stoffwechselkr; 1987; 47(6):337-40. PubMed ID: 3129277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human prolactin and thyrotropin concentrations in the serums of normal and hypopituitary children before and after the administration of synthetic thyrotropin-releasing hormone.
    Foley TP; Jacobs LS; Hoffman W; Daughaday WH; Blizzard RM
    J Clin Invest; 1972 Aug; 51(8):2143-50. PubMed ID: 4626583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hyperthyroidism and subjects hyperresponding to thyrotropin. Importance of simultaneous thyrotropin and prolactin determination following administration of thyroid-releasing hormone].
    Schlienger JL; De Laharpe F; Reville P; Stephan F
    Sem Hop; 1980 May 8-15; 56(17-18):827-31. PubMed ID: 6248964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Etiology and diagnosis of Basedow's disease].
    Nakai T
    Rinsho Byori; 1984 Jan; Spec No 58():120-9. PubMed ID: 6088843
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effect of thyrostatic treatment on circulating thyrotropin-receptor antibodies in Basedow's disease].
    Lozanov B; Kirilov G; Ivanova R; Khubaveshki S
    Vutr Boles; 1990; 29(3):79-84. PubMed ID: 1704667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum concentrations of thyroxine, 3,5,3'-triiodothyronine, thyrotropin, and prolactin in dogs before and after thyrotropin-releasing hormone administration.
    Kaufman J; Olson PN; Reimers TJ; Allen TA; Soderberg SF; Nett TM; Wheeler SL; Wingfield WE
    Am J Vet Res; 1985 Feb; 46(2):486-92. PubMed ID: 3922262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.